Oct 2026
A multi-omics integration identifies ENY2 hypomethylation as a driver of immunosuppression and progression in breast cancer.
Aberrant DNA methylation contributes to breast cancer (BC) progression and immune microenvironment dysregulation, but its underlying epigenetic-immune crosstalk remains poorly defined. This study constructed a methylation-driven prognostic signature in BC using the SIMPO algorithm and Cox regression with TCGA cohort da...
Hong Wang, Yan-Min Yu, Ling-Jia Meng et al.
· Cellular Signalling · 0 citations